One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.1182/blood.v128.22.473.473
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Dec 2, 2016 |
 Citations: 6 |
Affiliation: Hackensack University Medical Center, Karmanos Cancer Institute, Carolinas Healthcare System, Levine Cancer Institute, Vanderbilt University, University of Florida, Cedars-Sinai Medical Center, Comprehensive Cancer Centers of Nevada, Pharmacyclics (United States), AbbVie (United States), Cornell University
A Multicenter Open-Label, Phase 1b/2 Study of Ibrutinib in Combination with Lenalidomide and Rituximab in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
